• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

New York Lawmakers Propose Psychedelics Legalization Bill

Jason Najum by Jason Najum
January 3, 2023
in Law & Politics
Reading Time: 2 mins read
A A
New York Lawmakers Propose Psychedelics Legalization Bill

The state of New York has helped start 2023 with some good psychedelic news, announcing a bill to legalize some psychedelics for adults 21 and older.

The proposed legislation would amend current law to legalize the “possession, use, cultivation, production, creation, analysis, gifting, exchange, or sharing by or between natural persons of twenty-one years of age or older of a natural plant or fungus-based hallucinogen.”

Compounds covered by this bill would include: DMT, ibogaine, mescaline, psilocybin and psilocyn would fall under the definition of “natural plant or fungus-based hallucinogens” that would be legalized by the bill.

Some other highlights from the proposed legislation:

[bsa_pro_ad_space id=2]
ADVERTISEMENT
  • Authorize people to engage in psychedelic services “with or without remuneration”.
  • Allow the use of entheogens in religious ceremonies.
  • State and local law enforcement would be prohibited from cooperating or providing assistance to the federal government if the activities were made legal under the new NY state law.
  • Lasix Now Available
  • Employers would be barred from taking adverse action against a worker for lawfully using psychedelics off duty.
  • People could not lose their professional licenses, public assistance or be denied mental health or behavioral health services simply for using psychedelics.
  • Lawful use of psychedelics couldn’t be the sole basis for a child welfare investigation.
  • The proposal bill would remove psilocybin, psilocyn, DMT, mescaline and ibogaine from the state’s banned substances list.

This a comprehensive and progressive bill proposal, one that could have some legs as New York has just begun its legal cannabis sales this week.

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

The legislation is being proposed this week and is sponsored by assemblymember members Linda Rosenthal (D), Jo Anne Simon (D) and Karines Reyes (D).

 

 

For more on this, check out California Introduces New Bill to Decriminalize Psychedelics

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalization
Jason Najum

Jason Najum

Jason Najum's work has appeared in many industry-leading publications, covering topics ranging from cleantech start-ups to travel and culture. He's currently Microdose's Managing Editor and Senior Writer. Write him at jason@microdose.buzz and see his work at www.jasonnajum.com

Next Post
Top 3 Psychedelic Storylines to Watch in 2023

Top 3 Psychedelic Storylines to Watch in 2023

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.